# Staccato Prochlorperazine in Migraine (in Clinic)

> **NCT00610428** · PHASE2 · COMPLETED · sponsor: **Alexza Pharmaceuticals, Inc.** · enrollment: 75 (actual)

## Conditions studied

- Migraine Headache, With or Without Aura

## Interventions

- **DRUG:** Staccato Placebo
- **DRUG:** Staccato Prochlorperazine 5 mg
- **DRUG:** Staccato Prochlorperazine 10 mg

## Key facts

- **NCT ID:** NCT00610428
- **Lead sponsor:** Alexza Pharmaceuticals, Inc.
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00610428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00610428, "Staccato Prochlorperazine in Migraine (in Clinic)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00610428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*